Safety and efficacy of the Android Artificial System (AAPS) with advanced bolus-free features in Adults with Type 1 diabetes with extended use.(Close It Extended)
Not Applicable
- Conditions
- Type 1 Diabetes MellitusMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12624000575538
- Lead Sponsor
- Baker Heart and Diabetes Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
•Type 1 diabetes > 6 months duration
•Adults aged 18-70 years
•Completion of the CLOSE IT trial (ACTRN12622001401741) and willingness for ongoing use of a FCL system
Exclusion Criteria
•Pregnancy or planning a pregnancy in the next 12 months
•Chronic kidney disease (eGFR<45ml/min/1.73m2)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method